CD86 and Parkinson disease: Furthermore, it was observed that Myeloid DCs, HVEM on CD45RA− CD4+ T cells, CD62L− CD86+ Myeloid DCs, and HLA DR on monocytes exerted a protective causal effect against the development of PD.